Kepenekian, V., Péron, J., You, B., & Glehen, O. (2022). ASO Author Reflections: Bi-Directional Chemotherapy Using PIPAC Could Downstage Nonresectable Malignant Peritoneal Mesothelioma Patients to a Complete Resection. Annals of surgical oncology, 29(3), 2114-2115. https://doi.org/10.1245/s10434-021-10990-3
Chicago Style (17th ed.) CitationKepenekian, Vahan, Julien Péron, Benoit You, and Olivier Glehen. "ASO Author Reflections: Bi-Directional Chemotherapy Using PIPAC Could Downstage Nonresectable Malignant Peritoneal Mesothelioma Patients to a Complete Resection." Annals of Surgical Oncology 29, no. 3 (2022): 2114-2115. https://doi.org/10.1245/s10434-021-10990-3.
MLA (9th ed.) CitationKepenekian, Vahan, et al. "ASO Author Reflections: Bi-Directional Chemotherapy Using PIPAC Could Downstage Nonresectable Malignant Peritoneal Mesothelioma Patients to a Complete Resection." Annals of Surgical Oncology, vol. 29, no. 3, 2022, pp. 2114-2115, https://doi.org/10.1245/s10434-021-10990-3.